Healthcare - Biotechnology - NASDAQ - US
$ 15.83
-5.72 %
$ 1.35 B
Market Cap
-4.31
P/E
CASH FLOW STATEMENT
-161 M
OPERATING CASH FLOW
118 M
INVESTING CASH FLOW
264 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Syndax Pharmaceuticals, Inc.
| Net Income | -209 M |
| Depreciation & Amortization | 12 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 31 M |
| Change in Working Capital | 31.9 M |
| Others | 12.2 M |
| Free Cash Flow | -161 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (209.4) | (149.3) | 24.9 | (73.2) | (56.0) | (74.0) | (60.8) | (44.5) | (24.1) | (19.8) | (14.2) | (10.0) |
| Depreciation & Amortization | 12 K | 33 K | 43 K | 89 K | 92 K | 78 K | 76 K | 89 K | 21 K | 15 K | 13 K | 34 K |
| Deferred Income Tax | 0 | 0 | 0.3 | (0.1) | (0.8) | (0.6) | 0.2 | 1.6 | 2.5 | 2.6 | 1.7 | (3.4) |
| Stock Based Compensation | 31.0 | 16.0 | 13.3 | 9.1 | 6.0 | 6.2 | 5.5 | 4.7 | 3.9 | 2.3 | 1.4 | 0.1 |
| Other Operating Activities | (14.1) | (2.0) | 0.2 | 0.8 | 0.4 | 11 K | 8 K | 25 K | 0.8 | 40 K | 3.7 | 3.1 |
| Change in Working Capital | 31.9 | 1.7 | (9.6) | (7.9) | (0.2) | (0.3) | 7.7 | 2.9 | 14.6 | 0.6 | 31 K | 0.8 |
| Cash From Operations | (160.6) | (133.7) | 29.1 | (71.3) | (50.6) | (68.5) | (47.4) | (35.2) | (2.4) | (14.4) | (7.3) | (9.3) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | 0 | (0.2) | (0.1) | 0 | 0 | (0.2) | 84 K | (0.3) | 49 K | 4 K | 38 K | 11 K |
| Other Items | 117.6 | (186.0) | (40.7) | (142.5) | 12.8 | 51.6 | (16.9) | (18.1) | (61.6) | 1.9 | (4.0) | 0.5 |
| Cash From Investing Activities | 117.6 | (186.2) | (40.9) | (142.5) | 12.8 | 51.4 | (17.0) | (18.4) | (61.7) | 1.9 | (4.0) | 0.5 |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | (21.0) | 0 | 19.7 | 0 | 0 | 0 | 0 | (9.0) | 14.0 | (3.7) | 6.3 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (2.6) | 0 | 0 | 0 | 0 |
| Other Financing Activities | 6.0 | 11.9 | 32.1 | 6.6 | 0.4 | 0.2 | 0.4 | 4.7 | 86.3 | (1.6) | 50.7 | (0.6) |
| Cash From Financing Activities | 264.1 | 172.3 | 118.5 | 304.4 | 28.6 | 15.7 | 75.7 | 54.2 | 77.3 | 12.4 | 20.9 | 5.7 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 221.1 | (147.6) | 106.7 | 90.6 | (9.3) | (1.4) | 11.3 | 0.7 | 13.2 | 95 K | 9.6 | (3.1) |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (160.6) | (133.9) | 29.0 | (71.3) | (50.6) | (68.7) | (47.5) | (35.4) | (2.5) | (14.4) | (7.3) | (9.3) |